Ionizable Nano‐PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression
Angewandte Chemie International Edition · 16.01.2026 · 65 (3)
DOI: 10.1002/anie.202520235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 23.11.2025. Verfasst von Huan Min und 10 weiteren Autor:innen. Beteiligte Einrichtung: Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, 450003, China. Hauptthemen laut MEDLINE: Endosomes, Glycoproteins, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Henan Provincial Science and Technology Research and Development Plan Joint Fund.
Abstract (Originalsprache)
Nanoscale proteolysis‐targeting chimeras (nano‐PROTACs) have emerged as a promising modality that circumvents conventional linker optimization using multivalent engineering. However, their therapeutic potential remains severely limited by inefficient cytosolic delivery caused by endosomal entrapment. To address this challenge, we integrated a tertiary‐amine motif into amphiphilic conjugates, which co‐assemble into nano‐PROTACs (designed as i16‐ET NC ) optimized for protein degradation. Mechanistically, i16‐ET NC exploits a synergistic dual mechanism in which the ionizable tertiary amine cooperates with a C16 hydrophobic tail to enhance cellular uptake and promote endosomal escape via proton sponge effects, enabling efficient delivery to the cytosol. This design achieves potent degradation of the oncogenic target leucine‐rich α‐2‐glycoprotein 1 (LRG1) in 4T1 murine breast tumors. Systematic evaluation shows that i16‐ET NC effectively induces LRG1 degradation, leading to significant tumor growth inhibition, strong apoptosis induction, and notable tumor regression, all without detectable systemic toxicity. Overall, this study presents a broadly applicable strategy to address endosomal entrapment in targeted protein degradation, highlighting the therapeutic potential of nano‐PROTACs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, 450003, China.
- Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
- School of Nanoscience and Engineering, School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing, 101408, China.
- CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, 11 Beiyitiao, Zhongguancun, Beijing, 100190, China.
ORCID-Profile: Huan Min
Förderung
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research and Development Plan Joint Fund
Zitieren
APA
Min, H., Sun, M. C., Hu, K., Zhang, Y., Li, J., Li, Y., Du, L., Ding, W., Zhang, Y., Nie, G., & Qi, Y. (2026). Ionizable Nano‐PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression. Angewandte Chemie International Edition, 65(3). https://doi.org/10.1002/anie.202520235
Vancouver
Min H, Sun MC, Hu K, Zhang Y, Li J, Li Y, et al. Ionizable Nano‐PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression. Angewandte Chemie International Edition. 2026;65(3). doi:10.1002/anie.202520235
BibTeX
@article{Min2026,
author = {Min, Huan and Sun, Ming Chao and Hu, Kaijing and Zhang, Yana and Li, Junyao and Li, Yongzheng and Du, Lin and Ding, Wei and Zhang, Yinlong and Nie, Guangjun and Qi, Yingqiu},
title = {Ionizable Nano‐PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {3},
doi = {10.1002/anie.202520235}
}
EUVIMED